Clinical Trials Logo

Epilepsies, Partial clinical trials

View clinical trials related to Epilepsies, Partial.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT04998123 Not yet recruiting - Seizures Clinical Trials

Efficacy of Intersectional Short Pulse Stimulation for Terminating Seizures

Start date: January 2025
Phase: N/A
Study type: Interventional

This is a study which seeks to develop a novel therapeutic approach, Intersectional Short Pulse (ISP) stimulation for seizure termination. The device embodiment of ISP is a scalp EEG recording system which also delivers spatially precise electrical stimulation in short pulses to the targeted brain region. The study team has already collected safety and tolerability data in human subjects, demonstrated ISP efficacy in terminating seizures in rodents, and have tested the efficacy of this device to modulate normal human brain activity. Now this study proposes to test the device's efficacy in stopping seizures in a within-subject randomized, sham-controlled study design.

NCT ID: NCT04653012 Not yet recruiting - Cognitive Function Clinical Trials

Multi-level Approach of Brain Activity Using Intracranial Electrodes in Epileptic Patients

EpiMicro
Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The main goal of this project is to study the mechanisms of epileptic activities using intracranial macro and micro electrodes in epileptic patients undergoing pre-surgical investigation. The recordings will also be used to study physiological mechanisms like sleep and different cognitive functions.

NCT ID: NCT00851331 Not yet recruiting - Epilepsy Clinical Trials

Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits

Start date: n/a
Phase: N/A
Study type: Interventional

Epilepsy is a frequent neurological disease in childhood, characterized by recurrent seizures and sometimes with major effects on social, behavioral and cognitive development. Childhood focal epilepsies particularly are age-related diseases mainly occurring during developmental critical period. A complex interplay between brain development and maturation processes and susceptibility genes may contribute to the development of various childhood epileptic syndromes associated with language and cognitive deficits. Indeed, the Landau-Kleffner syndrome (LKS), the continuous spike-and-waves during sleep syndrome (CSWS), and the benign childhood epilepsy with centrotemporal spikes (BCECTS) or benign rolandic epilepsy, are different syndromes that are considered as part of a single continuous spectrum of disorders. While genetic component in those three syndromes remains elusive, novel and high throughput genome analyzes could bring interesting insights into the possible genetic defects and pathophysiological mechanisms underlying and linking the various disorders associating epilepsy with speech and cognitive impairments.